Back
Sage Therapeutics Stock Predictions
Trade Alert: Your First Two (Money Doubling?) Trades
Claim your first two trades here.
Sell
26
SAGE
Sage Therapeutics
Last Price:
$8.68
Seasonality Move:
-10.13%
7 Day Trial
ALL ACCESS PASS
$
7
Access Before Tuesday...
Grab your first two primed-to-double trades here.Sage Therapeutics Stock Forecast
-
Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.5% based on the past 11 years of stock performance.
-
Sage Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Sage Therapeutics Stock Undervalued?The current Sage Therapeutics [SAGE] share price is $8.68. The Score for SAGE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.5% based on the past 11 years of stock performance.
Sage Therapeutics Stock Rating
Sell
26
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
-
Sage Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
9.36
52-Week Low:
4.62
Prediction Charts
Market Cap:
544.9M
Price in USD:
8.68
Volume:
0
Beta:
1.31
Technical Analysis
SMA50:
8.27
SMA100:
7.85
SMA200:
7.16
52-Wk Change:
-9.58%
Stock Predictions
-
Is Sage Therapeutics stock public?Yes, Sage Therapeutics is a publicly traded company.
-
What is the Sage Therapeutics stock quote today?The Sage Therapeutics stock price is 8.68 USD today.
-
How to buy Sage Therapeutics stock online?You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-16 | 9.18 | 9.13 | 9.19 | 9.11 |
| Jul-17 | 9.16 | 9.14 | 9.17 | 9.13 |
| Jul-18 | 9.16 | 9.11 | 9.17 | 9.10 |
| Jul-21 | 9.08 | 8.97 | 9.11 | 8.96 |
| Jul-22 | 8.84 | 8.75 | 8.86 | 8.74 |
| Jul-23 | 8.78 | 8.77 | 8.80 | 8.71 |
| Jul-24 | 8.75 | 8.76 | 8.79 | 8.75 |
| Jul-25 | 8.79 | 8.80 | 8.82 | 8.76 |
| Jul-28 | 8.80 | 8.78 | 8.81 | 8.77 |
| Jul-29 | 8.76 | 8.70 | 8.77 | 8.70 |
| Jul-30 | 8.74 | 8.68 | 8.74 | 8.68 |
| Jul-31 | 8.68 | 8.68 | 8.68 | 8.68 |
| Aug-1 | 8.68 | 8.68 | 8.68 | 8.68 |
| Aug-4 | 8.68 | 8.68 | 8.68 | 8.68 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.43 per share, an increase this year of $2.77 per share, and an increase next year of $0.89 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.